Akizawa, Tadao
,
Shimazaki, Ryutaro
Shiramoto, Masanari
Fukagawa, Masafumi
Article History
First Online: 10 January 2019
Compliance with Ethical Standards
:
: No funding was received to assist in the preparation of this response.
: TA has received consulting fees from Kyowa Hakko Kirin Co, Ltd, Astellas Pharma Inc., Bayer Yakuhin, Ltd, Fuso Pharmaceutical Industries, Ltd, Japan Tobacco Inc., Ono Pharmaceutical Co, Ltd and NIPRO Industry; as well as lecture fees from Kyowa Hakko Kirin Co., Ltd, Chugai Pharmaceutical Co., Ltd, Bayer Yakuhin, Ltd, Kissei Pharmaceutical Co, Ltd, Torii Pharmaceutical Co, Ltd, and Ono Pharmaceutical Co., Ltd. RS is employed by Kyowa Hakko Kirin Co., Ltd, which funded the original research. MF has received consulting fees from Kyowa Hakko Kirin Co., Ltd and Ono Pharmaceutical Co. Ltd; as well as lecture fees from Kyowa Hakko Kirin Co., Ltd, Bayer Yakuhin, Ltd, Torii Pharmaceutical Co., Ltd and Ono Pharmaceutical Co., Ltd, and grants from Kyowa Hakko Kirin Co., Ltd and Bayer Yakuhin Ltd. MS has no conflicts of interest to declare.